Generic drugmaker Impax Labs in talks to merge with Amneal - WSJ

Sept 21 (Reuters) - Impax Laboratories Inc is in talks to merge with Amneal Pharmaceuticals LLC, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.